CLINICAL_TRIALS
withdrawal
· 2013-03-22
Clinical Trial Update: Garlic in Hyperlipidemia Caused by HAART [Phase 2]
Summary
This update indicates a Phase 2 trial evaluating garlic for HAART-induced hyperlipidemia in people with HIV has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: HIV Infections, Hypercholesterolemia | Phase 2 | Status: WITHDRAWN